Clinical Diagnostics News and Research

RSS

MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology.

From MGI 18 Sep 2023

Late life depression: Bridging the gap with new perspectives on aging

Researchers explore the interplay between late life depression and aging.

14 Aug 2023

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Researchers at the Ludwig Center at Harvard have developed a platform technology for imaging that enables integration of the methods of microscopic analysis long employed in pathology laboratories with the visualization of multiple molecular markers in individual cells that is now rapidly advancing in research labs.

22 Jun 2023

Investigating the relationship between red blood cells and the clinical course of COVID-19 in children

Study investigates the characteristics of RBCs after SARS-CoV-2.

20 Jun 2023

Biosensor Versatility; From Analytical Chemistry to Diagnostics

At Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Ralph N. Adams Award in Analytical Chemistry, Professor Joseph Wang to discuss the versatility of biosensor technologies.

From Pittcon 18 May 2023

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

Tuberculosis is caused by a bacterium that has evolved to evade the body’s immune system; now, its natural enemy, a phage, is being used to detect the infection at an early stage.

18 May 2023

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

The scientific foundation needed to work on curing a class of cancer-causing mutations is here, in the form of a tool from St. Jude Children's Research Hospital.

5 Apr 2023

BioEcho launches EchoLUTION™ FFPE DNA Kit for a simplified DNA extraction from FFPE samples

BioEcho Life Sciences, the biotechnology company delivering rapid and sustainable nucleic acid extraction products, announces the EchoLUTION FFPE DNA Kit release, for an innovative way to extract DNA from any kind of FFPE sample.

From BioEcho Life Sciences GmbH 27 Mar 2023

BioEcho receives patent for its EchoLUTION™ technology in the U.S. and Japan

BioEcho announces the grant of two patents for the innovative EchoLUTION™ technology transforming established nucleic acid extraction procedures.

From BioEcho Life Sciences GmbH 17 Feb 2023

New biosensor chip may increase accessibility to high-quality diagnostics

DNA can signal the presence of or predisposition to a slew of diseases, including cancer. The ability to flag down these clues, known as biomarkers, allows medical professionals to make critical early diagnoses and provide personalized treatments.

24 Jan 2023

Evosep receives strategic investment from Novo Holding A/S to accelerate its effort on clinical proteomics

Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics.

From Evosep 10 Jan 2023

Clinically relevant biomarker strategies in drug development

In this interview, NewsMedical speaks with Dr. Justin Devine and Dr. Nicholas Woudberg about biomarkers, their importance for drug development as well as the potential they have when it comes to machine learning.

From Synexa Life Sciences BV 9 Jan 2023

EKF launches handheld veterinary lactate analyzer

...

From EKF Diagnostics 22 Dec 2022

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

...

From The Native Antigen Company 8 Dec 2022

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.

From The Native Antigen Company 23 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

From The Native Antigen Company 21 Nov 2022

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

From The Native Antigen Company 7 Nov 2022

AI models improve the accuracy of diagnosing coronary artery disease

Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.

28 Oct 2022

New lab technique could spark a 'paradigm shift' in testing protein-based drugs

New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a "paradigm shift" in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.

27 Sep 2022

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

In a new study, a team of researchers explored the effect of immune checkpoint blockade (ICB)-induced expansion of age-associated B cells (ABCs) on COVID-19 vaccine-derived humoral immunity in patients with cancer and inborn errors of immunity (IEI).

22 Sep 2022